These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20370656)

  • 1. Adenosine receptor modeling: what does the A2A crystal structure tell us?
    Dal Ben D; Lambertucci C; Marucci G; Volpini R; Cristalli G
    Curr Top Med Chem; 2010; 10(10):993-1018. PubMed ID: 20370656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.
    Ivanov AA; Barak D; Jacobson KA
    J Med Chem; 2009 May; 52(10):3284-92. PubMed ID: 19402631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
    Sherbiny FF; Schiedel AC; Maass A; Müller CE
    J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.
    Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A
    J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.
    Tebben AJ; Schnur DM
    Methods Mol Biol; 2011; 672():359-86. PubMed ID: 20838977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technology.
    Morizzo E; Federico S; Spalluto G; Moro S
    Curr Pharm Des; 2009; 15(35):4069-84. PubMed ID: 20028322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
    Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
    Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists.
    Kolb P; Phan K; Gao ZG; Marko AC; Sali A; Jacobson KA
    PLoS One; 2012; 7(11):e49910. PubMed ID: 23185482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the adenosine receptors: implications for drug discovery.
    Lane JR; Jaakola VP; Ijzerman AP
    Adv Pharmacol; 2011; 61():1-40. PubMed ID: 21586354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
    Costanzi S
    J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study.
    Ciancetta A; Cuzzolin A; Moro S
    J Chem Inf Model; 2014 Aug; 54(8):2243-54. PubMed ID: 25046649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure based prediction of subtype-selectivity for adenosine receptor antagonists.
    Katritch V; Kufareva I; Abagyan R
    Neuropharmacology; 2011 Jan; 60(1):108-15. PubMed ID: 20637786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern homology modeling of G-protein coupled receptors: which structural template to use?
    Mobarec JC; Sanchez R; Filizola M
    J Med Chem; 2009 Aug; 52(16):5207-16. PubMed ID: 19627087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
    Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of adenosine receptors: new results and trends.
    Martinelli A; Tuccinardi T
    Med Res Rev; 2008 Mar; 28(2):247-77. PubMed ID: 17492754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding.
    Ivanov AA; Baskin II; Palyulin VA; Zefirov NS
    Dokl Biochem Biophys; 2002; 386():271-4. PubMed ID: 12469507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.